跳至主要内容
临床试验/NCT04649671
NCT04649671终止不适用

The Effect of Mobile Health-based Exercise on Insulin Sensitivity in Hepatocellular Carcinoma Patients With Insulin Resistance: A Randomized Controlled Trial

Samsung Medical Center2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2021年3月2日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
15
试验地点
2
主要终点
Improvement of insulin resistance

研究概览

简要总结

Exercise is predicted to have positive effect among patients with hepatocellular carcinoma (HCC). However, little attention has been paid to the role of physical activity with wearable device in the management of HCC patients in the aspect of improvement in insulin resistance.

We designed this study to investigate whether personalized exercise with mobile health program improves insulin resistance without decompensation in HCC patients with insulin resistance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 20 to 70 years
  • Patients who were diagnosed with early-stage HCC, defined by modified UICC stage 1 or 2
  • Patients with treatment-naive and recurrent HCC who have received treatment and achieved complete response at the time of screening
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
  • Patients with insulin resistance (HOMA-IR >=2.2)

排除标准

  • Child Pugh class B or C
  • Alcohol intake >20g/day
  • History of decompensation
  • Severe medical comorbidities (ischemic heart disease, 3rd degree atrioventricular block, chronic obstructive pulmonary disease, severe hypertension (blood pressure > 200/120 mmHg) or psychiatric illnesses which limit ability to exercise safely
  • Who takes insulin sensitizer (sulfonylurea, biguanide, thiazolidinedione, glucagon-like peptide-1 agonist, dipeptidyl peptidase-4 inhibitor) or uses insulin
  • Uncontrolled diabetes mellitus (Hemoglobin A1c >10%)

结局指标

主要结局

Improvement of insulin resistance

时间窗: After 12 weeks

The proportion of normalization of homeostatic model assessment of insulin resistance (HOMA-IR) (\<2.2)

次要结局

  • Improvement of 6-minute walk test(After 12 and 24 weeks)
  • Improvement of grip strength test(After 12 and 24 weeks)
  • Improvement of 30-second chair stand test(After 12 and 24 weeks)
  • Improvement of the score of International Physical Activity Questionnaire-Short Form (IPAQ-SF)(After 12 and 24 weeks)
  • Improvement of quality of life(After 12 and 24 weeks)
  • Improvement of insulin resistance(After 24 weeks)
  • Nutritional status(After 12 and 24 weeks)
  • Adverse events(After 12 and 24 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Moon Seok Choi

Professor

Samsung Medical Center

研究点 (2)

Loading locations...

相似试验